In the current study, we aimed to stratify HCC patients by cluster analysis of mRNA expression of EGFR, VEGFR2, PDGFRβ, FGFR1, and mTOR, which are major targets for molecular targeted therapy, as actionable molecules. This evidence concerns the gene PDGFRB and hepatocellular carcinoma.